BACKGROUND: People with multiple sclerosis (MS) fall frequently, and there are few clinically valid tools to measure the risk factors for falls. We assessed the unidimensionality of the 7-item Falls Efficacy Scale-International (FES-I), a measure of fear of falling, and determined whether the 7-item FES-I is associated with recurrent falls in people with MS. METHODS: Falls were counted prospectively for 6 months using fall calendars in 58 people with MS (age, 18-50 years; Expanded Disability Status Scale score, 0-6). The FES-I was administered at baseline, and its unidimensionality was assessed by confirmatory factor analysis. The relationship between FES-I score and future falls, after adjusting for recurrent falls in the past year, was assessed by logistic regression. RESULTS: Fifty-four participants who completed all assessments were included in the analysis. Goodness-of-fit indices confirmed a single-factor solution for the 7-item FES-I (discrepancy χ(2), P = .101; Tucker-Lewis index, 0.953; comparative fit index, 0.969; root mean square error of approximation, 0.098). There was a significant association between fear of falling and falls in the following 3 months, independent of recurrent falls in the past year (odds ratio = 1.22, 95% confidence interval, 1.04-1.43, P = .016). CONCLUSIONS: The 7-item FES-I demonstrates good construct validity, allowing the total score to be used as a measure of fear of falling in people with MS. Fear of falling, as measured by the 7-item FES-I, is associated with future recurrent falls independent of past recurrent falls in people with MS.
BACKGROUND:People with multiple sclerosis (MS) fall frequently, and there are few clinically valid tools to measure the risk factors for falls. We assessed the unidimensionality of the 7-item Falls Efficacy Scale-International (FES-I), a measure of fear of falling, and determined whether the 7-item FES-I is associated with recurrent falls in people with MS. METHODS:Falls were counted prospectively for 6 months using fall calendars in 58 people with MS (age, 18-50 years; Expanded Disability Status Scale score, 0-6). The FES-I was administered at baseline, and its unidimensionality was assessed by confirmatory factor analysis. The relationship between FES-I score and future falls, after adjusting for recurrent falls in the past year, was assessed by logistic regression. RESULTS: Fifty-four participants who completed all assessments were included in the analysis. Goodness-of-fit indices confirmed a single-factor solution for the 7-item FES-I (discrepancy χ(2), P = .101; Tucker-Lewis index, 0.953; comparative fit index, 0.969; root mean square error of approximation, 0.098). There was a significant association between fear of falling and falls in the following 3 months, independent of recurrent falls in the past year (odds ratio = 1.22, 95% confidence interval, 1.04-1.43, P = .016). CONCLUSIONS: The 7-item FES-I demonstrates good construct validity, allowing the total score to be used as a measure of fear of falling in people with MS. Fear of falling, as measured by the 7-item FES-I, is associated with future recurrent falls independent of past recurrent falls in people with MS.
Authors: Susan L Kasser; Jesse V Jacobs; Benjamin Littenberg; John T Foley; Bradley J Cardinal; Gianni F Maddalozzo Journal: Am J Phys Med Rehabil Date: 2014-06 Impact factor: 2.159
Authors: Patricia N Matsuda; Anne Shumway-Cook; Alyssa M Bamer; Shana L Johnson; Dagmar Amtmann; George H Kraft Journal: PM R Date: 2011-07 Impact factor: 2.298
Authors: Gertrudis I J M Kempen; Lucy Yardley; Jolanda C M van Haastregt; G A Rixt Zijlstra; Nina Beyer; Klaus Hauer; Chris Todd Journal: Age Ageing Date: 2007-11-20 Impact factor: 10.668
Authors: Kim Delbaere; Jacqueline C T Close; A Stefanie Mikolaizak; Perminder S Sachdev; Henry Brodaty; Stephen R Lord Journal: Age Ageing Date: 2010-01-08 Impact factor: 10.668
Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422
Authors: A Perrochon; R Holtzer; M Laidet; S Armand; F Assal; P H Lalive; G Allali Journal: J Neural Transm (Vienna) Date: 2016-12-22 Impact factor: 3.575